Jeanmarie Guenot, Ph.D. has more than 20 years of experience specifically in the pharmaceutical as well as biotechnology industry. There are all kinds of companies that she has worked with. These include public and private, besides pharmaceutical R&D, as well as in corporate & commercial development. She has also worked in business development, project as well as alliance management besides venture capital. She has considerable expertise as well as interest in building or even rebuilding of companies. Currently Jeanmarie Guenot is the President & CEO of Amphivena Therapeutics, Inc. This company is engaged in developing highly innovative bi-functional antibody therapies for various hematologic malignancies.
Before this Dr. Guenot founded, built as well as ran SKS Ocular. This is a start-up ophthalmic company incubator. It is focused on dry AMD, sustained release ocular drug delivery technologies along with therapeutics for glaucoma, macular degeneration as well as ocular inflammation. Guenot has been a business advisor for Hoffmann-La Roche in Basel and Shanghai on guenotllc.com. Earlier she was the Vice President of Corporate & Business Development at PDL BioPharma. Here she was into licensing, mergers and acquisitions along with alliance management for PDL’s R&D as well as commercial product portfolios.
Guenot led and even negotiated the Biogen Idec-PDL 50:50, co-development, along with co-commercialization collaboration. This involved three Phase 2 cancers as well as autoimmune disease drug candidates. It is $800 million transaction. This included a $100 million equity investment in PDL along with a therapeutic candidate with indications that are split between Biogen Idec/PDL and Hoffmann-La Roche.
Guenot is responsible for licensing the ophthalmic indication for its oncology drug to Ophthotech. This indicates that she has portfolio, project as well as alliance management experience on amphivena.com. All this is in the areas of oncology, cardiovascular diseases in addition to autoimmune diseases besides neurology and ophthalmic diseases.
The business career of Jeanmarie Guenot started at Atlas Venture. Here she managed venture capital investments while building life science companies. Her scientific career began as a principal scientist. This was in Preclinical R&D at Hoffmann-La Roche. Here she discovered and developed drugs for metabolic diseases, inflammation as well as autoimmune diseases besides oncology.